the role of ctdna in hodgkin lymphoma
Published 1 year ago • 103 plays • Length 1:37Download video MP4
Download video MP3
Similar videos
-
1:21
chep-bv followed by bv consolidation in cd30-expressing ptcl
-
1:06
molecules versus cells for hodgkin lymphoma management
-
6:24
tnb-486: interim results of a cd19/cd3 t-cell engager in r/r follicular lymphoma
-
2:29
evaluating the combination of nivolumab and lenalidomide in relapsed hl and lbcl
-
1:11
improving outcomes in hodgkin lymphoma
-
1:57
el panorama actual de la inmunoterapia para linfoma de hodgkin
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
1:15
biomarkers being explored in hodgkin lymphoma: the role of ctdna
-
3:56
phase i study of tinostamustine in pre-treated patients with r/r hodgkin lymphoma
-
1:27
tp53-aberrant mcl: challenges and treatment approaches
-
1:32
gore c3 excluder aaa endoprosthesis deployment
-
2:19
addition of inotuzumab to allosct conditioning regimen in relapsed cd22 ( ) lymphoid malignancies
-
1:06
targeting tcf3-hlf−positive all
-
5:24
safety by treatment phase and age when treating flt3-itd-mutated aml with quizartinib and chemo
-
2:44
azacitidine, venetoclax & gilteritinib in older/unfit patients with flt3-mutated aml
-
1:29
bispecific bcma-cd3 antibody teclistamab is efficacious and tolerable in r/r mm
-
2:39
advancements in bispecific and trispecific antibodies for the treatment of lymphoma
-
12:21
non-hodgkin lymphoma - causes, symptoms, diagnosis, treatment, pathology
-
4:14
duvelisib, dual inhibitor of pi3k delta and pi3k gamma, for indolent non-hodgkin lymphoma